Literature DB >> 9564837

Regulation of cyclooxygenase-2 and prostaglandin F synthase gene expression by steroid hormones and interferon-tau in bovine endometrial cells.

C W Xiao1, J M Liu, J Sirois, A K Goff.   

Abstract

Estradiol (E2) and progesterone are responsible for regulating PG synthesis in the endometrium during the estrous cycle and interferon-tau (IFN-tau) alters PG synthesis during early pregnancy in ruminants. In this study, we examined the effects of these steroid hormones and recombinant bovine IFN-tau (rbIFN-tau) on PG production and on cyclooxygenase-2 (COX-2) and PG F (PGF) synthase (PGFS) gene expression in isolated endometrial cells. E2 decreased both PGF2alpha and PG E2 (PGE2) whereas progesterone increased PGF2alpha secretion in epithelial cells. Steroid hormones had no effect on PG production in stromal cells. rbIFN-tau attenuated both PGF2alpha and PGE2 production in epithelial cells and enhanced their production, and the ratio of PGE2 to PGF2alpha, in stromal cells. Northern blot analysis showed that E2 and rbIFN-tau decreased COX-2 messenger RNA (mRNA) levels in epithelial cells. Conversely, rbIFN-tau increased COX-2 mRNA in stromal cells. Furthermore, rbIFN-tau decreased PGFS mRNA in both cell types and this was associated with the increase in PGE2/PGF2alpha ratio. These results show that the regulation of PG synthesis by steroid hormones is different in endometrial epithelial and stromal cells in vitro. The attenuation of PGF2alpha secretion from epithelial cells and increased PGE2 production in stromal cells by rbIFN-tau are modulated by steroid hormones.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9564837     DOI: 10.1210/endo.139.5.5961

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  7 in total

1.  Expression of cyclooxygenase 2 is an independent prognostic factor in human ovarian carcinoma.

Authors:  Carsten Denkert; Martin Köbel; Sören Pest; Ines Koch; Stefan Berger; Michael Schwabe; Antje Siegert; Angela Reles; Bernd Klosterhalfen; Steffen Hauptmann
Journal:  Am J Pathol       Date:  2002-03       Impact factor: 4.307

2.  Bacterial lipopolysaccharide induces an endocrine switch from prostaglandin F2alpha to prostaglandin E2 in bovine endometrium.

Authors:  Shan Herath; Sonia T Lilly; Deborah P Fischer; Erin J Williams; Hilary Dobson; Clare E Bryant; I Martin Sheldon
Journal:  Endocrinology       Date:  2008-12-04       Impact factor: 4.736

3.  Role of follicular estradiol-17beta in timing of luteolysis in heifers.

Authors:  Reno R Araujo; O J Ginther; Jair C Ferreira; Miller M Palhão; Mohd A Beg; Milo C Wiltbank
Journal:  Biol Reprod       Date:  2009-03-04       Impact factor: 4.285

4.  Bovine embryo induces an anti-inflammatory response in uterine epithelial cells and immune cells in vitro: possible involvement of interferon tau as an intermediator.

Authors:  Anup K Talukder; Mohamed S Yousef; Mohammad B Rashid; Kensuke Awai; Tomas J Acosta; Takashi Shimizu; Kiyoshi Okuda; Masayuki Shimada; Kazuhiko Imakawa; Akio Miyamoto
Journal:  J Reprod Dev       Date:  2017-06-10       Impact factor: 2.214

5.  PKC epsilon and an increase in intracellular calcium concentration are necessary for PGF2 alpha to inhibit LH-stimulated progesterone secretion in cultured bovine steroidogenic luteal cells.

Authors:  Madhusudan P Goravanahally; Aritro Sen; Emmet K Inskeep; Jorge A Flores
Journal:  Reprod Biol Endocrinol       Date:  2007-08-30       Impact factor: 5.211

6.  Effects of the estrous cycle, pregnancy and interferon tau on expression of cyclooxygenase two (COX-2) in ovine endometrium.

Authors:  Seokwoon Kim; Youngsok Choi; Thomas E Spencer; Fuller W Bazer
Journal:  Reprod Biol Endocrinol       Date:  2003-08-20       Impact factor: 5.211

7.  Biological activity of recombinant bovine interferon τ produced by a silkworm-baculovirus gene expression system.

Authors:  Hitomi Takahashi; Makoto Tsunazaki; Takashi Hamano; Masashi Takahashi; Kiyoshi Okuda; Shigeki Inumaru; Akira Okano; Masaya Geshi; Makoto Hirako
Journal:  J Vet Med Sci       Date:  2013-11-11       Impact factor: 1.267

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.